These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2118231

  • 1. Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo.
    Lähdetie J, Räty R, Sorsa M.
    Mutat Res; 1990 Sep; 245(1):27-32. PubMed ID: 2118231
    [Abstract] [Full Text] [Related]

  • 2. In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide--a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity.
    Pool BL, Bos RP, Niemeyer U, Theuws JL, Schmähl D.
    Toxicol Lett; 1988 Apr; 41(1):49-56. PubMed ID: 3128896
    [Abstract] [Full Text] [Related]

  • 3. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
    Kunze E, Köhnecke B, Engelhardt W, Steinröder H, Brock N, Pohl J.
    Urol Int; 1984 Apr; 39(2):61-7. PubMed ID: 6426112
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
    Wilmer JL, Erexson GL, Kligerman AD.
    Cancer Res; 1986 Jan; 46(1):203-10. PubMed ID: 3079586
    [Abstract] [Full Text] [Related]

  • 5. Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats.
    Slott VL, Hales BF.
    Toxicol Appl Pharmacol; 1986 Jan; 82(1):80-6. PubMed ID: 3080822
    [Abstract] [Full Text] [Related]

  • 6. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
    Habs MR, Schmähl D.
    Cancer; 1983 Feb 15; 51(4):606-9. PubMed ID: 6401591
    [Abstract] [Full Text] [Related]

  • 7. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
    Brock N, Pohl J, Stekar J, Scheef W.
    Eur J Cancer Clin Oncol; 1982 Dec 15; 18(12):1377-87. PubMed ID: 6819957
    [Abstract] [Full Text] [Related]

  • 8. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Schmähl D, Habs M, Tacchi AM.
    Urologe A; 1984 Sep 15; 23(5):291-6. PubMed ID: 6438859
    [Abstract] [Full Text] [Related]

  • 9. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N, Stekar J.
    Arzneimittelforschung; 1982 Sep 15; 32(5):486-7. PubMed ID: 6809014
    [Abstract] [Full Text] [Related]

  • 10. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
    Cavalletti E, Tofanetti O, Zunino F.
    Cancer Lett; 1986 Jul 15; 32(1):1-6. PubMed ID: 3091245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
    Kedar A, Simpson CL, Williams P, Moore R, Tritsch G, Murphy GP.
    Res Commun Chem Pathol Pharmacol; 1980 Aug 15; 29(2):339-48. PubMed ID: 6774389
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.
    Al-Safi SA, Maddocks JL.
    Br J Clin Pharmacol; 1986 Mar 15; 21(3):267-70. PubMed ID: 2938613
    [Abstract] [Full Text] [Related]

  • 17. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A, Korkmaz A, Oter S, Coskun O.
    Arch Toxicol; 2005 Aug 15; 79(8):461-5. PubMed ID: 15800758
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetic testing of mutagenic and radioprotective effects of mesna.
    Becher R, Kakati S, Gibas Z, Sandberg AA.
    Oncology; 1983 Aug 15; 40(4):287-9. PubMed ID: 6408550
    [Abstract] [Full Text] [Related]

  • 19. Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna.
    Keles I, Bozkurt MF, Cemek M, Karalar M, Hazini A, Alpdagtas S, Keles H, Yildiz T, Ceylan C, Buyukokuroglu ME.
    Int Urol Nephrol; 2014 Dec 15; 46(12):2301-10. PubMed ID: 25248628
    [Abstract] [Full Text] [Related]

  • 20. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Brock N, Pohl J, Stekar J.
    J Cancer Res Clin Oncol; 1981 Dec 15; 100(3):311-20. PubMed ID: 6792207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.